PRULIFLOXACIN VERSUS LEVOFLOXACIN IN PATIENTS WITH ACUTE BACTERIAL RHINOSINUSITIS ABRS

Trial Profile

PRULIFLOXACIN VERSUS LEVOFLOXACIN IN PATIENTS WITH ACUTE BACTERIAL RHINOSINUSITIS ABRS

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Nov 2016

At a glance

  • Drugs Prulifloxacin (Primary) ; Levofloxacin
  • Indications Bacterial infections; Rhinosinusitis
  • Focus Therapeutic Use
  • Sponsors Angelini Group
  • Most Recent Events

    • 09 Nov 2016 Status changed from recruiting to completed.
    • 30 Jun 2011 This trial is recruiting in Hungary and Spain and has been completed in Italy and Austria.
    • 30 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top